Clinical Study

Efficacy And Safety Of Pozelimab And Cemdisiran Combination Therapy In Patients With Symptomatic Generalized Myasthenia Gravis

Posted Date: Nov 12, 2021

  • Investigator: Hani Kushlaf
  • Specialties:
  • Type of Study: Drug

The primary objective of the study is to evaluate the effect of pozelimab + cemdisiran on daily functioning that is impacted by signs and symptoms in patients with symptomatic generalized myasthenia gravis (gMG).




Myasthenia Gravis, Mg

For More Information:

Ashley Smith

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.